These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 1713709)

  • 1. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
    Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT
    Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats.
    Jyotheeswaran S; Li P; Chang TM; Chey WY
    Pancreas; 2000 May; 20(4):401-7. PubMed ID: 10824696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans.
    Lam WF; Masclee AA; Souverijn JH; Lamers CB
    Life Sci; 1999; 64(8):617-26. PubMed ID: 10069525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)].
    Creutzfeldt W; Lankisch PG; Fölsch UR
    Dtsch Med Wochenschr; 1975 May; 100(20):1135-8. PubMed ID: 1126301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A; Kulesza E; Konturek SJ
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels.
    Beglinger C; Fried M; Whitehouse I; Jansen JB; Lamers CB; Gyr K
    J Clin Invest; 1985 May; 75(5):1471-6. PubMed ID: 3998145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.
    Watanabe S; Takeuchi T; Chey WY
    Gastroenterology; 1992 Feb; 102(2):621-8. PubMed ID: 1732130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of secretin and cholecystokinin in oleic acid-stimulated pancreatic secretion in rats.
    Shiratori K; Watanabe S; Takeuchi T; Shimizu K; Moriyoshi Y
    Gastroenterol Jpn; 1990 Feb; 25(1):104-11. PubMed ID: 1689684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs.
    Chey WY; Lee KY; Chang TM; Chen YF; Millikan L
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G248-52. PubMed ID: 6322594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
    Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potentiating effect of secretin on cholecystokinin-stimulated exocrine pancreatic secretion in rats].
    Moriyoshi Y
    Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2425-33. PubMed ID: 2480464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pancreatic polypeptide on the pancreatic exocrine secretion stimulated by secretin and cholecystokinin in the conscious pig.
    Langlois A; Corring T; Cuber JC; Gueugneau AM; Levenez F; Chayvialle JA
    Regul Pept; 1989 Jan; 24(1):55-65. PubMed ID: 2740529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of insulin and glucose on basal and cholecystokinin-stimulated exocrine pancreatic secretion in humans.
    Lam WF; Gielkens HA; Coenraad M; Souverijn JH; Lamers CB; Masclee AA
    Pancreas; 1999 Apr; 18(3):252-8. PubMed ID: 10206483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man.
    Kerstens PJ; Lamers CB; Jansen JB; de Jong AJ; Hessels M; Hafkenscheid JC
    Life Sci; 1985 Feb; 36(6):565-9. PubMed ID: 3968978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans.
    Thimister PW; Hopman WP; Tangerman A; Rosenbusch G; Willems HL; Jansen JB
    Hepatology; 1998 Dec; 28(6):1454-60. PubMed ID: 9828206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans.
    You CH; Rominger JM; Chey WY
    Gastroenterology; 1983 Jul; 85(1):40-5. PubMed ID: 6303892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.